These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 35680788)

  • 1. [Clinical Significance of Low Expression of LncRNA CASC15 in Acute Myeloid Leukemia with NPM1 Mutations].
    Xia PH; Xu ZJ; Jin Y; Ma JC; Wen XM; Yuan Q; Leng JY; Qian J; Lin J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):659-670. PubMed ID: 35680788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1.
    Cheng Z; Dai Y; Pang Y; Jiao Y; Zhao H; Wu S; Zhang L; Zhang Y; Wang X; Wang L; Ma D; Qin T; Hu N; Zhang Y; Hu K; Zhang Q; Shi J; Fu L
    Cell Physiol Biochem; 2018; 47(5):1853-1861. PubMed ID: 29961066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALOX5AP is a new prognostic indicator in acute myeloid leukemia.
    Chen XY; Wen XM; Zhao W; Chu MQ; Gu Y; Huang HH; Yuan Q; Xu ZJ; Qian J; Lin J
    Discov Oncol; 2023 Nov; 14(1):210. PubMed ID: 37994961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
    Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H
    Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant NPM1-regulated lncRNA HOTAIRM1 promotes leukemia cell autophagy and proliferation by targeting EGR1 and ULK3.
    Jing Y; Jiang X; Lei L; Peng M; Ren J; Xiao Q; Tao Y; Tao Y; Huang J; Wang L; Tang Y; Yang Z; Yang Z; Zhang L
    J Exp Clin Cancer Res; 2021 Oct; 40(1):312. PubMed ID: 34615546
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Bai H; Zhou M; Zeng M; Han L
    DNA Cell Biol; 2020 Apr; 39(4):700-708. PubMed ID: 32077754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome.
    Mason EF; Hasserjian RP; Aggarwal N; Seegmiller AC; Pozdnyakova O
    Blood Adv; 2019 Nov; 3(21):3322-3332. PubMed ID: 31698462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid sarcoma with
    Ramia de Cap M; Wu LP; Hirt C; Pihan GA; Patel SS; Tam W; Bueso-Ramos CE; Kanagal-Shamanna R; Raess PW; Siddon A; Narayanan D; Morgan EA; Pinkus GS; Mason EF; Hsi ED; Rogers HJ; Toth L; Foucar K; Hurwitz SN; Bagg A; Rets A; George TI; Orazi A; Arber DA; Hasserjian RP; Weinberg OK;
    Leuk Lymphoma; 2023 May; 64(5):972-980. PubMed ID: 36960680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TG-interacting factor 1 improves risk stratification in patients with NPM1-mutated acute myeloid leukemia.
    Tang H; Zhang N; Li H; Chen Y; Liu X; Xiao H; Deng J; Zhou K
    Adv Clin Exp Med; 2023 Jul; 32(7):741-751. PubMed ID: 36753372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non‑coding RNA ANRIL is a potential indicator of disease progression and poor prognosis in acute myeloid leukemia.
    Tan Z; Zhu K; Yin Y; Luo Z
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [NPM1 High Mutant Allele Burden is an Adverse Prognostic Factor for AML Patients with Mutated NPM1].
    Hou JX; Wang SJ; Liu YF; Hao QQ; Wang C; Li T; Bai JJ; Liao LX; Guo CY; Chang YY; Wang M; Sun H; Xie XS; Jiang ZX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):365-372. PubMed ID: 30998139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic mutation-associated risk index based on lncRNA expression for predicting prognosis in acute myeloid leukemia.
    Xu Q; Guo T
    Hematology; 2022 Dec; 27(1):659-671. PubMed ID: 35666642
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic relevance of combined IDH1 and NPM1 mutations in the intermediate cytogenetic de novo acute myeloid leukemia.
    Abd El-Lateef AE; Ismail MM; Almohammadi M; Gawaly AM
    Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):92-98. PubMed ID: 34933728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic significance of different IDH mutations and accompanying gene mutations in patients with acute myeloid leukemia].
    Wu RY; Xie XS; Wei Y; Jang ZX; Chen DD; Sun H; Wan DM; Liu YF; Sun L
    Zhonghua Xue Ye Xue Za Zhi; 2021 Jan; 42(1):39-44. PubMed ID: 33677867
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia.
    Shamaa S; Laimon N; Aladle DA; Azmy E; Elghannam DM; Salem DA; Taalab MM
    Hematology; 2014 Jan; 19(1):22-30. PubMed ID: 23540998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution from an antecedent chronic myeloid malignancy does not impact survival outcomes in NPM1-mutated AML.
    Smith E; Atenafu EG; Bankar A; Chan S; Davidson M; Gupta V; Minden MD; Richard-Carpentier G; Schimmer A; Schuh AC; Sibai H; Yee K; Maze D
    Eur J Haematol; 2024 Nov; 113(5):716-726. PubMed ID: 39113600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleophosmin mutation in de-novo acute myeloid leukemia.
    Rastogi P; Naseem S; Varma N; Varma S
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):77-85. PubMed ID: 26669619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXC chemokine receptor 4 expression, CXC chemokine receptor 4 activation, and wild-type nucleophosmin are independently associated with unfavorable prognosis in patients with acute myeloid leukemia.
    Konoplev S; Lin P; Yin CC; Lin E; Nogueras González GM; Kantarjian HM; Andreeff M; Medeiros LJ; Konopleva M
    Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):686-92. PubMed ID: 24035716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia.
    Patel JL; Schumacher JA; Frizzell K; Sorrells S; Shen W; Clayton A; Jattani R; Kelley TW
    Leuk Res; 2017 May; 56():7-12. PubMed ID: 28152414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic localization of nucleophosmin in bone marrow blasts of acute myeloid leukemia patients is not completely concordant with NPM1 mutation and is not predictive of prognosis.
    Konoplev S; Huang X; Drabkin HA; Koeppen H; Jones D; Kantarjian HM; Garcia-Manero G; Chen W; Medeiros LJ; Bueso-Ramos CE
    Cancer; 2009 Oct; 115(20):4737-44. PubMed ID: 19637342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.